EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 53 / No 3 (September 2021) J Extra Corpor Technol, 53 3 (2021) 170-176 References
Free Access
Issue
J Extra Corpor Technol
Volume 53, Number 3, September 2021
Page(s) 170 - 176
DOI https://doi.org/10.1051/ject/202153170
Published online 15 September 2021
  1. Comunale ME, Maslow A, Robertson LK, et al. Effect of site of venous protamine administration, previously alleged risk factors, and preoperative use of aspirin on acute protamine-induced pulmonary vasoconstriction. J Cardiothorac Vasc Anesth. 2003;17:309–13. [CrossRef] [Google Scholar]
  2. Mclaughlin KE, Dunning J. In patients post cardiac surgery do high doses of protamine cause increased bleeding? Interact Cardiovasc Thorac Surg. 2003;2:424–6. [CrossRef] [Google Scholar]
  3. Nybo M, Madsen JS. Serious anaphylactic reactions due to protamine sulfate: A systematic literature review. Basic Clin Pharmacol Toxicol. 2008;103:192–6. [CrossRef] [Google Scholar]
  4. Meesters MI, Veerhoek D, de Lange F, et al. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. Thromb Haemost. 2016;116:251–61. [CrossRef] [PubMed] [Google Scholar]
  5. Boer C, Meesters MI, Veerhoek D, et al. Anticoagulant and side-effects of protamine in cardiac surgery: A narrative review. Br J Anaesth. 2018;120:914–27. [CrossRef] [Google Scholar]
  6. Valchanov K, Falter F, George S, et al. Three cases of anaphylaxis to protamine: management of anticoagulation reversal. J Cardiothorac Vasc Anesth. 2019;33:482–6. [CrossRef] [Google Scholar]
  7. Hecht P, Besser M, Falter F. Are we able to dose protamine accurately yet? A review of the protamine conundrum. J Extra Corpor Technol. 2020;52:63–70. [Google Scholar]
  8. Jobes DR, Aitken GL, Shaffer GW. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. J Thorac Cardiovasc Surg. 1995;110:36–45. [CrossRef] [Google Scholar]
  9. Koster A, Börgermann J, Gummert J, et al. Protamine overdose and its impact on coagulation, bleeding, and transfusions after cardiopulmonary bypass: Results of a randomized double-blind controlled pilot study. Clin Appl Thromb Hemost. 2014;20:290–5. [CrossRef] [PubMed] [Google Scholar]
  10. Kunz SA, Miles LF, Ianno DJ, et al. The effect of protamine dosing variation on bleeding and transfusion after heparinisation for cardiopulmonary bypass. Perfusion. 2018;33:445–52. [CrossRef] [PubMed] [Google Scholar]
  11. Mochizuki T, Olson PJ, Szlam F, et al. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg. 1998;87:781–5. [CrossRef] [PubMed] [Google Scholar]
  12. Abuelkasem E, Mazzeffi MA, Henderson RA, et al. Clinical impact of protamine titration-based heparin neutralization in patients undergoing coronary bypass grafting surgery. J Cardiothorac Vasc Anesth. 2019;33:2153–60. [CrossRef] [Google Scholar]
  13. Lindblad B, Wakefield TW, Whitehouse WM, et al. The effect of protamine sulfate on platelet function. Scand J Thorac Cardiovasc Surg. 1988;22:55–9. [CrossRef] [PubMed] [Google Scholar]
  14. Ammar T, Fisher CF. The effects of heparinase 1 and protamine on platelet reactivity. Anesthesiology. 1997;86:1382–6. [CrossRef] [PubMed] [Google Scholar]
  15. Shigeta O, Kojima H, Hiramatsu Y, et al. Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1999;118:354–60. [CrossRef] [Google Scholar]
  16. Cuenca JS, Diz PG, Sampedro FG, et al. Method to calculate the protamine dose necessary for reversal of heparin as a function of activated clotting time in patients undergoing cardiac surgery. J Extra Corpor Technol. 2013;45:235. [Google Scholar]
  17. Davidsson FÖ, Johagen D, Appelblad M, et al. Reversal of heparin after cardiac surgery: Protamine titration using a statistical model. J Cardiothorac Vasc Anesth. 2015;29:710–4. [CrossRef] [Google Scholar]
  18. Suelzu S, Cossu A, Pala G, et al. Impact of different dosage of protamine on heparin reversal during off-pump coronary artery bypass: A clinical study. Heart Lung Vessel. 2015;7:238. [Google Scholar]
  19. Meesters MI, Veerhoek D, de Jong JR, et al. A pharmacokinetic model for protamine dosing after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2016;30:1190–5. [CrossRef] [Google Scholar]
  20. Hällgren O, Svenmarker S, Appelblad M. Implementing a statistical model for protamine titration: Effects on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth. 2017;31:516–21. [CrossRef] [Google Scholar]
  21. Goedhart AL, Gerritse BM, Rettig TC, et al. A 0.6-protamine/heparin ratio in cardiac surgery is associated with decreased transfusion of blood products. Interact Cardiovasc Thorac Surg. 2020;31:391–7. [CrossRef] [Google Scholar]
  22. Lee MH, Riley W. Factors associated with errors in the heparin dose response test: Recommendations to improve individualized heparin management in cardiopulmonary bypass. Perfusion. 2021;36:513–23. [CrossRef] [PubMed] [Google Scholar]
  23. Ural K, Owen C. Pro: The Hepcon HMS should be used instead of traditional activated clotting time (ACT) to dose heparin and protamine for cardiac surgery requiring cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2016;30:1727–9. [CrossRef] [Google Scholar]
  24. Manual O. Hepcon® HMS Plus Hemostatis Management System. Multichannel Clot Timing Instrument With Automated Pipetting; 2012–29. [Google Scholar]
  25. Allen TH, Peng MT, Chen KP, et al. Prediction of blood volume and adiposity in man from body weight and cube of height. Metabolism. 1956;5:328–45. [Google Scholar]
  26. Altman DG, Bland JM. Improving doctors’ understanding of statistics. J R Stat Soc Ser A Stat Soc. 1991;154:223–48. [CrossRef] [Google Scholar]
  27. Giavarina D. Understanding bland altman analysis. Biochem Med (Zagreb). 2015;25:141–51. [CrossRef] [Google Scholar]
  28. Lee MH, Gisnarian CJ, Shann KG. Improved estimation of total blood volume can provide a reliable prediction of dilutional hematocrit and oxygen delivery during cardiopulmonary bypass. J Extra Corpor Technol. 2019;51:67–72. [Google Scholar]
  29. Li H, Serrick C, Rao V, et al. A comparative analysis of four activated clotting time measurement devices in cardiac surgery with cardiopulmonary bypass. Perfusion. 2020. doi: 10.1177/0267659120949351. [Google Scholar]
  30. Vranken NP, Theelen AJ, Orbons T, et al. Point-of-care measurement of kaolin activated clotting time during cardiopulmonary bypass: A single sample comparison between ACT plus and i-STAT. J Extra Corpor Technol. 2021;53:57–61. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.